Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.
Int J Obes (Lond). 2011 Feb;35(2):270-8. doi: 10.1038/ijo.2010.134. Epub 2010 Jul 27.
We previously demonstrated in an animal model that steatosis, in the absence of fibrosis, induces a significant rise in portal pressure, indicating substantial changes in liver hemodynamics. As assessment of portal pressure is an invasive procedure, non-invasive parameters are needed to identify patients at risk.
To study the portal pressure in nonalcoholic fatty liver disease patients and to identify factors that are possibly related to steatosis-induced changes in liver hemodynamics.
Patients presenting with a problem of overweight or obesity, and in whom non-invasive investigations showed signs of liver involvement, were proposed for transjugular hepatic vein catheterization and liver biopsy. The biopsy was scored according to the Nonalcoholic Steatohepatitis Clinical Research Network Scoring System.
A total of 50 consecutive patients were studied. Their mean age was 47.9 ± 1.8 years; 31 (62%) were female. Hepatic venous pressure gradient was normal in 36 (72%) and elevated in 14 (28%) patients. The degree of steatosis was the only histological parameter that differed significantly between the two groups (P=0.016), and was a predictor of the presence of portal hypertension (PHT) in regression analysis (P=0.010). Comparing normal versus portal hypertensive patients, waist circumference (117 ± 2 versus 128 ± 4 cm, P=0.005), waist-hip ratio (0.96 ± 0.06 versus 1.04 ± 0.03, P=0.003), visceral fat (229 ± 15 versus 292 ± 35 cm(2), P=0.022), fasting insulin (15.4 ± 1.7 versus 21.8 ± 2.4 μU ml(-1), P=0.032), fasting c-peptide (1.22 ± 0.06 versus 1.49 ± 0.09 nmol l(-1), P=0.035) and homeostasis model assessment-insulin resistance (HOMA IR) (3.28 ± 0.29 versus 4.81 ± 0.57, P=0.019) were significantly higher. Age, gender, liver enzymes, ferritin and high-sensitive C-reactive protein were not significantly different. In regression analysis, waist circumference (P=0.008) and HOMA IR (P=0.043) were independent predictors of PHT.
Estimates of both visceral adiposity and IR are predictors for the presence of PHT, related to the degree of steatosis, and may help in identifying patients who are at risk of developing steatosis-related complications.
我们之前在动物模型中证明,在没有纤维化的情况下,脂肪变性会导致门静脉压力显著升高,表明肝脏血液动力学发生了实质性变化。由于门静脉压力评估是一种侵入性操作,因此需要非侵入性参数来识别有风险的患者。
研究非酒精性脂肪性肝病患者的门静脉压力,并确定可能与脂肪变性引起的肝脏血液动力学变化相关的因素。
对超重或肥胖的患者进行经颈静脉肝内门体分流术和肝活检的建议。活检根据非酒精性脂肪性肝炎临床研究网络评分系统进行评分。
共研究了 50 例连续患者。他们的平均年龄为 47.9±1.8 岁;31 名(62%)为女性。36 名(72%)患者的肝静脉压力梯度正常,14 名(28%)患者升高。两组之间仅组织学参数的脂肪变性程度有显著差异(P=0.016),并且是回归分析中门静脉高压(PHT)存在的预测因子(P=0.010)。比较正常与门脉高压患者,腰围(117±2 与 128±4cm,P=0.005)、腰臀比(0.96±0.06 与 1.04±0.03,P=0.003)、内脏脂肪(229±15 与 292±35cm(2),P=0.022)、空腹胰岛素(15.4±1.7 与 21.8±2.4μUml(-1),P=0.032)、空腹 C 肽(1.22±0.06 与 1.49±0.09nmol l(-1),P=0.035)和稳态模型评估-胰岛素抵抗(HOMA IR)(3.28±0.29 与 4.81±0.57,P=0.019)显著升高。年龄、性别、肝酶、铁蛋白和高敏 C 反应蛋白无显著差异。回归分析中,腰围(P=0.008)和 HOMA IR(P=0.043)是 PHT 的独立预测因子。
内脏脂肪堆积和 IR 的估计值是 PHT 存在的预测因子,与脂肪变性程度相关,可能有助于识别发生脂肪变性相关并发症的风险患者。